1st phorm l-carnitine with fucoxanthin Fuc – TrustScore® 6.4/10 1ST PHORM L-CARNITINE FOR FAT

Conflict of Interest The authors declare no competing interests

10.1016/j.cell.2011.02.013 Cell 109 HansenJ

European cancer mortality predictions for the year 2019 with focus on breast cancer

These data support the hypothesis that LA acts as a zonulin antagonist and demonstrates its potential for reducing onset of other disease conditions, aside from celiac disease

We then compared these data with our previously published transcriptomic dataset of perinatal fentanyl-exposed (PFE) mice, which exhibited similar affective disturbances [25], to assess molecular convergence at the level of gene targets rather than global pathway identity